For instance, CXCR5/TCF1+CD8+ T cells have been associated with durable responses to ICB therapy in lung cancer, while LAYN+CD8+ T cells have been found to be exhausted and contributed to non-response to immunotherapy. The gene discussed is CD8A; the disease is lung carcinoma.